Biocept, Inc. (BIOCQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 19, 2024, 4:00 PM EST
Biocept Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 1.36 | 25.86 | 61.25 | 27.46 | 5.53 | 3.25 | Upgrade
|
| Revenue Growth (YoY) | -97.63% | -57.78% | 123.04% | 396.71% | 70.09% | -35.87% | Upgrade
|
| Cost of Revenue | 15.66 | 28.44 | 37.76 | 21.34 | 10.98 | 10.05 | Upgrade
|
| Gross Profit | -14.3 | -2.58 | 23.49 | 6.12 | -5.45 | -6.8 | Upgrade
|
| Selling, General & Admin | 14.82 | 23.24 | 20.93 | 16.37 | 12.91 | 12.99 | Upgrade
|
| Research & Development | 4.04 | 6.16 | 4.96 | 5.22 | 4.7 | 4.47 | Upgrade
|
| Operating Expenses | 18.85 | 29.4 | 25.89 | 21.59 | 17.61 | 17.46 | Upgrade
|
| Operating Income | -33.16 | -31.98 | -2.41 | -15.47 | -23.06 | -24.26 | Upgrade
|
| Interest Expense | -0.2 | -0.32 | -0.29 | -0.24 | -0.25 | -0.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.62 | 0.09 | - | -2.1 | -1.83 | - | Upgrade
|
| Pretax Income | -30.73 | -32.21 | -2.7 | -17.81 | -25.14 | -24.57 | Upgrade
|
| Income Tax Expense | -0.13 | -0.13 | 0.13 | - | - | 0 | Upgrade
|
| Net Income | -30.61 | -32.09 | -2.82 | -17.81 | -25.14 | -24.57 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0 | 0.12 | 0.64 | Upgrade
|
| Net Income to Common | -30.61 | -32.09 | -2.82 | -17.81 | -25.26 | -25.21 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | 25.55% | 14.74% | 24.74% | 473.32% | - | - | Upgrade
|
| EPS (Basic) | -44.33 | -56.78 | -5.73 | -45.11 | -366.78 | - | Upgrade
|
| EPS (Diluted) | -44.33 | -56.78 | -5.73 | -45.11 | -366.90 | - | Upgrade
|
| Free Cash Flow | -18.28 | -14.1 | 2.12 | -20.65 | -23.78 | -22.5 | Upgrade
|
| Free Cash Flow Per Share | -26.47 | -24.94 | 4.30 | -52.31 | -345.36 | - | Upgrade
|
| Gross Margin | - | -9.99% | 38.34% | 22.30% | -98.56% | -209.26% | Upgrade
|
| Operating Margin | -2443.40% | -123.69% | -3.93% | -56.33% | -417.05% | -746.35% | Upgrade
|
| Profit Margin | -2255.49% | -124.09% | -4.61% | -64.86% | -456.89% | -775.56% | Upgrade
|
| Free Cash Flow Margin | -1346.87% | -54.51% | 3.46% | -75.21% | -430.21% | -692.26% | Upgrade
|
| EBITDA | -31.33 | -30.33 | -0.88 | -14.38 | -22.13 | -23.46 | Upgrade
|
| EBITDA Margin | - | -117.29% | -1.44% | -52.38% | - | - | Upgrade
|
| D&A For EBITDA | 1.83 | 1.66 | 1.53 | 1.09 | 0.93 | 0.8 | Upgrade
|
| EBIT | -33.16 | -31.98 | -2.41 | -15.47 | -23.06 | -24.26 | Upgrade
|
| EBIT Margin | - | -123.69% | -3.93% | -56.33% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.